Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: Missed opportunities for vaccination

Pay for Performance in Chronic Liver Disease

“…However, even in the absence of high quality randomized trial data, there is evidence that supports use of these processes in patients with HCV; these processes are also endorsed by the HCV clinical practice guidelines. [8][9][10] Beyond the scientific base supporting these measures, data show low and variable rates of meeting these measures in disparate healthcare settings and patient subgroups. Using a nationwide U.S private health insurance company research database, we found large variation in the degree to which patients met the HCV quality measures.…”

“…A C C E P T E D ACCEPTED MANUSCRIPT 8 The American Gastroenterological Association (AGA) Digestive Health Recognition Program (DHRP) is an example of a qualified registry that can collect and report data on HCV measures group. 15 Data can be entered manually on a web form that collects necessary information to calculate the numerators for all HCV measures.…”

Hepatitis C for Primary Care Physicians

“…19,20 Primary Care for Patients with Chronic Hepatitis C Patients who are not immune to hepatitis A or B should receive vaccination. 21,22 Patients with cirrhosis should also be offered pneumococcal vaccination and annual inactivated influenza vaccination. 23 All patients with chronic hepatitis C should be advised to abstain from drinking alcohol to decrease the risk of cirrhosis, and referral to treatment facilities should be provided.…”

Multicentric Evaluation of New Commercial Enzyme Immunoassays for the Detection of Immunoglobulin M and Total Antibodies against Hepatitis A Virus

“…With regard to adults, certain categories of people, such as men who have sexual intercourse with men, both injection and noninjection drug users, and travelers returning from developing countries, are exposed to a higher risk of infection and therefore are subjected to cyclic outbreaks of hepatitis A (1,3,8,11,12,15,17,18). It is also worth mentioning that HAVinfected persons with chronic liver disease are likely to develop fulminant hepatitis A (14,16). This global scenario of hepatitis A epidemiology calls for an increase in research to be carried out in the coming years and for measures to be taken to control and prevent the spread of this infectious disease.…”